BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6617038)

  • 1. Importance of proper staging in ovarian carcinoma.
    Piver MS
    Clin Obstet Gynaecol; 1983 Aug; 10(2):223-34. PubMed ID: 6617038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of subclinical metastasis in stage I and II ovarian carcinoma.
    Piver MS; Barlow JJ; Lele SB
    Obstet Gynecol; 1978 Jul; 52(1):100-4. PubMed ID: 683618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lymphatic spread among women with primary peritoneal carcinoma.
    Eltabbakh GH; Mount SL
    J Surg Oncol; 2002 Nov; 81(3):126-31. PubMed ID: 12407724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Surgical staging of carcinoma of the ovaries.
    Buchsbaum HJ; Brady MF; Delgado G; Miller A; Hoskins WJ; Manetta A; Sutton G
    Surg Gynecol Obstet; 1989 Sep; 169(3):226-32. PubMed ID: 2772792
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphatic mapping and sentinel node identification as related to the primary sites of lymph node metastasis in early stage ovarian cancer.
    Negishi H; Takeda M; Fujimoto T; Todo Y; Ebina Y; Watari H; Yamamoto R; Minakami H; Sakuragi N
    Gynecol Oncol; 2004 Jul; 94(1):161-6. PubMed ID: 15262135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surgical staging of ovarian low malignant potential tumors.
    Rao GG; Skinner E; Gehrig PA; Duska LR; Coleman RL; Schorge JO
    Obstet Gynecol; 2004 Aug; 104(2):261-6. PubMed ID: 15291997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laparoscopic surgical staging of ovarian cancer.
    Childers JM; Lang J; Surwit EA; Hatch KD
    Gynecol Oncol; 1995 Oct; 59(1):25-33. PubMed ID: 7557611
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastasis in stage I epithelial ovarian cancer.
    Suzuki M; Ohwada M; Yamada T; Kohno T; Sekiguchi I; Sato I
    Gynecol Oncol; 2000 Nov; 79(2):305-8. PubMed ID: 11063662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Laparoscopy as part of the evaluation and management of ovarian and cervix neoplasms].
    Ben David Y; Bustan M; Shalev E
    Harefuah; 2001 Jun; 140(6):464-7, 568. PubMed ID: 11420840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lymph node involvement in epithelial ovarian cancer: analysis of 276 pelvic and paraaortic lymphadenectomies and surgical implications.
    Morice P; Joulie F; Camatte S; Atallah D; Rouzier R; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D
    J Am Coll Surg; 2003 Aug; 197(2):198-205. PubMed ID: 12892797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Significance of lymph node sampling in epithelial carcinoma of the ovary.
    Carnino F; Fuda G; Ciccone G; Iskra L; Guercio E; Dadone D; Conte PF
    Gynecol Oncol; 1997 Jun; 65(3):467-72. PubMed ID: 9190977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does systematic lymphadenectomy have a benefit on survival of suboptimally debulked patients with stage III ovarian carcinoma? A DEGOG* Study.
    Saygili U; Guclu S; Uslu T; Erten O; Ture S; Demir N
    J Surg Oncol; 2002 Nov; 81(3):132-7. PubMed ID: 12407725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contralateral pelvic and aortic lymph node metastasis in clinical stage I epithelial ovarian cancer.
    Walter AJ; Magrina JF
    Gynecol Oncol; 1999 Jul; 74(1):128-9. PubMed ID: 10385564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on lymphadenectomy in early and advanced ovarian cancer.
    Angioli R; Plotti F; Palaia I; Calcagno M; Montera R; Cafà EV; Sereni MI; Panici PB
    Curr Opin Obstet Gynecol; 2008 Feb; 20(1):34-9. PubMed ID: 18197003
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The impact of bulky upper abdominal disease cephalad to the greater omentum on surgical outcome for stage IIIC epithelial ovarian, fallopian tube, and primary peritoneal cancer.
    Zivanovic O; Eisenhauer EL; Zhou Q; Iasonos A; Sabbatini P; Sonoda Y; Abu-Rustum NR; Barakat RR; Chi DS
    Gynecol Oncol; 2008 Feb; 108(2):287-92. PubMed ID: 17996927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lymph node metastasis in ovarian cancer: difference between serous and non-serous primary tumors.
    Takeshima N; Hirai Y; Umayahara K; Fujiwara K; Takizawa K; Hasumi K
    Gynecol Oncol; 2005 Nov; 99(2):427-31. PubMed ID: 16112718
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is it necessary to do retroperitoneal evaluation in borderline epithelial ovarian tumors?
    Pirimoglu ZM; Afsin Y; Guzelmeric K; Yilmaz M; Unal O; Turan MC
    Arch Gynecol Obstet; 2008 May; 277(5):411-4. PubMed ID: 17940784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.
    Watari H; Todo Y; Takeda M; Ebina Y; Yamamoto R; Sakuragi N
    Gynecol Oncol; 2005 Mar; 96(3):651-7. PubMed ID: 15721407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies in the management of ovarian cancer--pros and cons for lymph node dissection in ovarian cancer.
    Camara O; Sehouli J
    Anticancer Res; 2009 Jul; 29(7):2837-43. PubMed ID: 19596971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.